Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder
暂无分享,去创建一个
E. Masliah | I. Grant | R. Heaton | M. Mallory | R. Ellis | J. McCutchan | J. Atkinson | T. Marcotte | I. Everall | I. Everall | Rj Ellis | I. Everall | J. McCutchan | McCutchan Ja | J. Atkinson | I. Grant | RK Heaton | TD Marcotte
[1] R. DeTeresa,et al. Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.
[2] S. Lipton,et al. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.
[3] P. Lantos,et al. HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.
[4] P. Lantos,et al. Neuronal loss in the frontal cortex in HIV infection , 1991, The Lancet.
[5] E. Masliah,et al. Neocortical damage during HIV infection , 1991, Annals of neurology.
[6] Andrew J. Saykin,et al. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.
[7] C. Achim,et al. Selective Neuronal Vulnerability in HIV Encephalitis , 1992, Journal of neuropathology and experimental neurology.
[8] P. Lantos,et al. Neuronal loss in symptom-free HIV infection , 1992, The Lancet.
[9] E. Masliah,et al. Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.
[10] P. Lantos,et al. Neuronal number and volume alterations in the neocortex of HIV infected individuals. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[11] I Grant,et al. Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. , 1994, Psychosomatic medicine.
[12] M. Louder,et al. Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues , 1994, Neurology.
[13] E. Masliah,et al. Cytokine receptor alterations during HIV infection in the human central nervous system , 1994, Brain Research.
[14] C. Achim,et al. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome , 1994, Annals of neurology.
[15] C. Achim,et al. Brain Viral Burden in HIV Infection , 1994, Journal of neuropathology and experimental neurology.
[16] L. Mucke,et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. , 1994, Nature.
[17] E. Masliah,et al. Differential Vulnerability of Calbindin‐immunoreactive Neurons in HIV Encephalitis , 1995, Journal of neuropathology and experimental neurology.
[18] Michael J. Taylor,et al. The HNRC 500-Neuropsychology of Hiv infection at different disease stages , 1995, Journal of the International Neuropsychological Society.
[19] D. Rusyniak,et al. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures , 1995, Brain Research.
[20] J. Glass,et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.
[21] A. Nath,et al. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium , 1995, Brain Research.
[22] R. Kerwin,et al. Decreased expression of AMPA receptor messenger RNA and protein in AIDS: A model for HIV-associated neurotoxicity , 1995, Nature Medicine.
[23] R. Brownstone,et al. Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.
[24] P. Lantos,et al. Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. , 1996, The American journal of pathology.
[25] J. Glass,et al. Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia. , 1996, Journal of neuropathology and experimental neurology.
[26] F. Scaravilli,et al. HIV‐1 DNA in brains in AIDS and pre‐AIDS: Correlation with the stage of disease , 1996, Annals of neurology.
[27] B. Chesebro,et al. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome , 1996, Annals of neurology.
[28] E. Masliah,et al. Comparison of Two Quantitative Methods for the Evaluation of Neuronal Number in the Frontal Cortex in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[29] Peter R Mouton,et al. Empirical assessment of synapse numbers in primate neocortex , 1997, Journal of Neuroscience Methods.
[30] L. Thal,et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. , 1997, Archives of neurology.
[31] E. Masliah,et al. Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. , 1997, Gerontology.
[32] E. Masliah,et al. Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders , 1997, Annals of neurology.